Is There Any Role of DCB for the Treatment of De Novo Lesions? - Juan F. Granada, MD

↳ This is a section part of Moment: CRT 2015 Technology & Innovation - DCB Technology Symposium Part II

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Is There Any Role of DCB for the Treatment of De Novo Lesions? presented by Juan F. Granada, MD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows
  • Vascular Surgeons
  • Interventional Radiologists
  • Physicians with an interest in Cardiovascular Innovations 

Session Name: DCB Technology Symposium Part II

Track: Technology & Innovation

Learning Objectives

  • Updates in the latest Cardiovascular Innovations

Other Components in this Moment

Overview
DCB for In-Stent: Is It Superior To DES? - R. A. Byrne, MB BCh PhD
Is There Any Role of DCB for the Treatment of De Novo Lesions? - Juan F. Granada, MD
DCB as Adjunct Therapy to DES and BRS - Azeem Latib, MD
What Will be the Regulatory Requirements for DCB Approval for Coronary Application in the US? - Adrian Magee, MD
Lumen Enlargement After DCB Only - Bruno Scheller, MD
Loading Simple Education